Clinical Trial Update: PhysioFlow to Detect Cardiotoxicity in Chemo

View source ↗

Summary

This clinical trial update describes using PhysioFlow to detect chemotherapy-induced cardiotoxicity in cancer patients; the current status is listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Chemotherapy, Cancer, Cardiotoxicity, Physioflow | Status: UNKNOWN